Magnetar Financial sells Coreweave (CRWV) shares worth $97.2 million

Magnetar Financial LLC divested 739,303 shares of CoreWeave, Inc. for $97.2 million on September 22, 2025, even as CoreWeave reported a 12.19% weekly return and a $64.7 billion valuation, trading at premium multiples (P/B 26x, EV/EBITDA 44.7x). This institutional sale occurred amidst CoreWeave's recent announcements of a £1.5 billion UK AI data center expansion and a $6.3 billion order agreement with Nvidia, including a capacity purchase commitment through 2032, alongside varied analyst ratings from Equalweight to Buy.

Analysis

CoreWeave (CRWV) presents a complex picture of strong operational momentum contrasted with a significant insider sale. On the positive side, the company is executing an aggressive growth strategy, evidenced by a new £1.5 billion investment in UK AI data centers, which elevates its total commitment there to £2.5 billion. This expansion is underpinned by a substantial new $6.3 billion order agreement with Nvidia, which crucially includes a long-term commitment for Nvidia to purchase unsold capacity through April 2032, significantly de-risking future revenue streams. This positive news has contributed to a 12.19% weekly stock return and has drawn bullish analyst actions, including an upgrade to Market Outperform from Citizens JMP with a $180 price target. However, this optimism is tempered by two key factors. First, the stock trades at premium valuation multiples, with a Price-to-Book ratio of 26x and an EV/EBITDA multiple of 44.7x, alongside a 'FAIR' financial health score from InvestingPro. Second, and perhaps more notably, Magnetar Financial executed a large $97.2 million divestment, selling nearly 740,000 shares. This institutional profit-taking amidst a strong rally and high valuation suggests that some sophisticated investors may be capitalizing on the stock's recent strength.

Key Decisions for Investors

• Investors should weigh the significant insider selling from Magnetar Financial against CoreWeave's powerful growth catalysts, including its £2.5 billion UK expansion and the $6.3 billion long-term revenue agreement with Nvidia.
• Given the stock's premium valuation metrics (P/B of 26x, EV/EBITDA of 44.7x) and recent 12.19% weekly gain, it is critical to assess whether the positive operational news is already fully priced in, creating a risk of a valuation-driven pullback.
• Consider the divergence in analyst price targets, which range from $116 to $180, as an indicator of significant uncertainty in valuing the company's aggressive growth trajectory against its high current multiples.
• Monitor future insider transaction filings for further institutional profit-taking and track the execution of the Nvidia capacity agreement, as these will be key indicators of long-term confidence and operational success.